Bone marrow (BM) analysis revealed 95% pro-B-ALL blasts (CD19 + , CD22 + , HLA-DR + , CD10-, intermediate CD45), confirming the diagnosis of BCP-ALL without extramedullary disease. Here, PTPRC is linked to acute lymphoblastic leukemia.